Ocrevus (ocrelizumab) - Roche
Invasive Enterovirus and Parechovirus Infections in Adults, Alberta, Canada, 2023-2025. (PubMed, Emerg Infect Dis) - Oct 25, 2026 - "Severe disseminated enterovirus infection occurred in 2 patients who received ocrelizumab. Continuous surveillance and ongoing optimization of enterovirus and parechovirus detection assays is essential for comprehensive public health tracking." 
Journal • Retrospective data • CNS Disorders • Infectious Disease
http://www.ncbi.nlm.nih.gov/pubmed/42909846
 
Adil Adatia; Anita Wong; Dima Kabbani; Graham Tipples; Hong Yuan Zhou; Jamil N Kanji; Kanti Pabbaraju; Kara Gill; Nabeela Nathoo; Nathan Zelyas; Tarah Lynch
 
Oct 25, 2026
 
Prev Next